# Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells (Text with EEA relevance), Division 1.1.3

Extent: E+W+S+N.I.

Presence, or previous history, of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to scientific evidence. Donors with malignant diseases can be evaluated and considered for cornea donation, except for those with retinoblastoma, haematological neoplasm, and malignant tumours of the anterior segment of the eye.

---
Source: https://www.legislation.gov.uk/eudr/2006/17/annex/I/division/1/division/1.1/division/1.1.3 (the official version)
Page: https://openlegislation.uk/eu-directive-2006-17/annex-I/division-1/division-1.1/division-1.1.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.